Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.320
+0.030 (2.33%)
Aug 26, 2026, 2:13 PM EDT - Market open

Inovio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
136120661393891,050
Market Cap Growth
30.98%80.95%-52.55%-64.23%-62.93%-29.98%
Enterprise Value
10879-62140688
Last Close Price
1.291.741.836.1218.7259.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1829.48303.38167.3337.93591.53
PB Ratio
24.304.960.961.191.752.63
P/TBV Ratio
30.514.960.961.191.862.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1205.35-1.8613.62387.68

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.830.390.170.260.140.08
Net Debt / Equity Ratio
-6.56-2.04-1.20-0.98-0.99-0.92
Net Debt / EBITDA Ratio
0.370.570.740.930.891.24
Net Debt / FCF Ratio
0.360.550.790.921.021.70
Asset Turnover
-0.000.000.000.020.00
Quick Ratio
0.921.342.703.472.736.23
Current Ratio
1.001.402.773.603.256.82
Return on Equity (ROE)
-409.87%-183.47%-115.42%-79.55%-89.97%-70.55%
Return on Assets (ROA)
-84.23%-57.88%-49.45%-30.50%-37.53%-36.35%
Return on Capital Employed (ROCE)
-836.60%-283.30%-144.30%-98.70%-100.80%-70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-50.55%-71.06%-162.35%-97.05%-71.89%-28.93%
FCF Yield
-60.56%-74.38%-158.28%-89.56%-55.80%-20.66%
Buyback Yield / Dilution
-92.40%-72.63%-22.49%-11.51%-14.27%-34.62%
SEC Filings: 10-K · 10-Q